At a glance
ClinicalIndex Comparison RecordN/ACompleted· 191 enrolled
Drug / intervention
enVista® One-Piece Hydrophobic Acrylic Toric IOL +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
To Evaluate the Safety and Effectiveness of the EnVista® One-Piece Hydrophobic Acrylic Toric IOL Designed to Reduce the Effects of Preoperative Corneal Astigmatism on Postoperative Refraction Following Cataract Surgery
In Brief
A clinical study evaluating enVista® One-Piece Hydrophobic Acrylic Toric IOL and enVista control lens for Astigmatism. Completed, enrolled 191 participants across 1 site.
Detailed Summary
The investigational enVista IOL, Model MX60Tis equipped with toric optics and axis marks on the posterior surface to minimize the possibility of surgically induced astigmatism.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAstigmatism
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
Enrollment StartMar 2013
First PostedMay 2013
Primary CompletionJul 2016
Study CompletionDec 2016
TodayJul 2026
First PostedMay 13, 2013
Enrollment StartMar 6, 2013
Primary CompletionJul 18, 2016
Study CompletionDec 1, 2016
TodayJul 2, 2026
Enrollment to primary: 3.4 yearsPosted 13.1 years ago
Interventions
enVista® One-Piece Hydrophobic Acrylic Toric IOLdevice
Test lens having a toric cylinder power of either 1.25 diopters (D), 2.00 D, or 2.75 D
enVista control lensdevice
Spherical Control lens